Marcel Muelbaier
- Molecular Biology
- Oncology top 10%
- Organic Chemistry
- Hematology top 10%
- Spectroscopy top 10%
- Co-authors
- Marcus BantscheffJohn D. HarlingThilo WernerHan DaiCyrille S. KoundeEdward W. TateDouglas W. ThomsonM.D. Rackham
- Topics
- Protein Degradation and Inhibitors (6 papers)Ubiquitin and proteasome pathways (5 papers)Multiple Myeloma Research and Treatments (4 papers)
- Cited by
- Molecular BiologyHematologyOncology
- Journals
- Journal of the American Chemical SocietyAngewandte Chemie International EditionChemical Communications
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Marcel Muelbaier
15 papers receiving 812 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 689
- Oncology 233
- Organic Chemistry 137
- Hematology 107
- Spectroscopy 93
Countries citing papers authored by Marcel Muelbaier
This map shows the geographic impact of Marcel Muelbaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Muelbaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Muelbaier more than expected).
Fields of papers citing papers by Marcel Muelbaier
This network shows the impact of papers produced by Marcel Muelbaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Muelbaier. The network helps show where Marcel Muelbaier may publish in the future.
Co-authorship network of co-authors of Marcel Muelbaier
This figure shows the co-authorship network connecting the top 25 collaborators of Marcel Muelbaier. A scholar is included among the top collaborators of Marcel Muelbaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcel Muelbaier. Marcel Muelbaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 85 | |
| 4 | 4 | |
| 5 | 107 | |
| 6 | 134 | |
| 7 | 33 | |
| 8 | 66 | |
| 9 | 90 | |
| 10 | 24 | |
| 11 | 23 | |
| 12 | 165 | |
| 13 | 67 | |
| 14 | 23 | |
| 15 | 1 |
About Marcel Muelbaier
Marcel Muelbaier is a scholar working on Hematology, Genetics and Molecular Biology, having authored 15 papers that have together received 828 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Molecular Biology (689 citations), Hematology (107 citations) and Oncology (233 citations). Marcel Muelbaier has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Marcus Bantscheff, John D. Harling, Thilo Werner, Han Dai, Cyrille S. Kounde, Edward W. Tate, Douglas W. Thomson, M.D. Rackham, Maria M. Shchepinova and Paul F. Fitzpatrick. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.